Focus on knowledge creation

Without ideas there is nothing to manage

Synapse is the lead project manager for the EPAD project (European Prevention of Alzheimer’s Dementia Consortium), kicked-off on Jan 14-15, 2015 in Paris, which will work with 1.500 volunteers around Europe to participate in clinical trials towards the prevention of Alzheimer.
The EPAD project (www.ep-ad.org) is aimed at creating a platform for faster and better assessment of drugs for the prevention of Alzheimer’s dementia in people at risk of developing the disease, but with no or mild symptoms
A consortium of 35 academic institutions, pharmaceutical companies, SMEs and patient organisations have joined forces to develop this ambitious project, funded under the auspices of the Innovative Medicines Initiative (www.imi.europa.eu) programme.
Three Spanish organisations participation in the EPAD consortium:
– Synapse Research Management Partners SL (SYNAPSE)
– Barcelonabeta Brain Research Center (BBRC)
– Araclon Biotech S.L. (ARACLON)
The project is co-led by Janssen Pharmaceutica and the University of Edinburgh. Synapse co-leads the Project Management and Sustainability work packages.
For more information, please visit www.ep-ad.org or email us at info@ep-ad.org.